BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2776236)

  • 21. The combined effect of topical CX-659S, a novel diaminouracil derivative, with topical corticosteroid on the three types of allergic responses in mice or guinea pigs.
    Inoue Y; Isobe M; Hayashi H
    J Pharmacol Sci; 2003 Jan; 91(1):71-8. PubMed ID: 12686733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Derivatives of 2-bromo-6beta-fluoropregna-1,4-diene-3,20-dione and their antiinflammatory activity.
    Toscano L; Barlotti L; Fioriello G; Grisanti G; Bossoni G; Biraschi LM; Riva M
    Arzneimittelforschung; 1977; 27(9):1628-33. PubMed ID: 579127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study of the vasoconstrictor activity of halopredone acetate in a modified McKenzie test.
    Rampini E; Rastelli A; Cardo P
    Eur J Clin Pharmacol; 1978 Dec; 14(5):325-9. PubMed ID: 729625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substituted pyrazolo corticoids as topical antiinflammatory agents.
    Hannah J; Kelly K; Patchett AA
    J Med Chem; 1975 Feb; 18(2):168-72. PubMed ID: 1120984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological properties of a new non-fluorinated topical antiinflammatory steroid.
    Celasco G; Galletti F; Gardi R
    Farmaco Prat; 1980 Mar; 35(3):107-20. PubMed ID: 7439352
    [No Abstract]   [Full Text] [Related]  

  • 26. PEG mediated synthesis and pharmacological evaluation of some fluoro substituted pyrazoline derivatives as antiinflammatory and analgesic agents.
    Jadhav SY; Shirame SP; Kulkarni SD; Patil SB; Pasale SK; Bhosale RB
    Bioorg Med Chem Lett; 2013 May; 23(9):2575-8. PubMed ID: 23541672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measuring adrenal function in out-patients using topical corticosteroids.
    Sparkes CG
    Br J Dermatol; 1976 Mar; 94 suppl 12():77-82. PubMed ID: 1268080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical mometasone furoate and betamethasone-17-valerate decrease collagen synthesis to a similar extent in human skin in vivo.
    Koivukangas V; Karvonen J; Risteli J; Oikarinen A
    Br J Dermatol; 1995 Jan; 132(1):66-8. PubMed ID: 7756153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of new antiinflammatory steroidal 20-carboxamides: (20R)- and (20S)-21-(N-substituted amino)-11 beta,17,20-trihydroxy-3,21-dioxo-1,4- pregnadiene.
    Kim HP; Bird J; Heiman AS; Hudson GF; Taraporewala IB; Lee HJ
    J Med Chem; 1987 Dec; 30(12):2239-44. PubMed ID: 3681894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The chamber vasoconstrictor assay. I. Comparison with occluded and unoccluded tests using four corticosteroids.
    Somerma S
    Clin Exp Dermatol; 1980 Jun; 5(2):191-6. PubMed ID: 7438514
    [No Abstract]   [Full Text] [Related]  

  • 31. Topical betamethasone 17-valerate is an anticorticosteroid in the rat. 1. Dermal atrophy.
    Young JM; Yoxall BE; Wagner BM
    Br J Dermatol; 1978 Dec; 99(6):655-63. PubMed ID: 737128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of glucocorticosteroids on epidermal Langerhans cells.
    Belsito DV; Flotte TJ; Lim HW; Baer RL; Thorbecke GJ; Gigli I
    J Exp Med; 1982 Jan; 155(1):291-302. PubMed ID: 6459400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study of systemic and topical effects of topical steroid application through the comparison of two application schedules.
    Fukaya Y; Masutani M; Koyama Y; Takahashi H; Ueda H
    J Dermatol; 1990 Jan; 17(1):28-33. PubMed ID: 2329214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anti-inflammatory effects of prednisolone 17-valerate 21-acetate, a new topical corticosteroid (author's transl)].
    Wada Y; Etoh Y; Ohira A; Ikuta J; Kato Y; Sano N
    Nihon Yakurigaku Zasshi; 1980 Sep; 76(5):333-45. PubMed ID: 7203275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An improved method of assessing topical corticosteroid activity.
    Barnes H; Gaylarde PM; Brock AP; Sarkany I
    Br J Dermatol; 1975 Oct; 93(4):459-64. PubMed ID: 1201192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Properties and therapeutic uses of some corticosteroids with enhanced topical potency.
    Harris DM
    J Steroid Biochem; 1975 May; 6(5):711-6. PubMed ID: 1186253
    [No Abstract]   [Full Text] [Related]  

  • 37. A new efficient method for conversion of corticosteroid 17 alpha,21-cyclic ortho esters to 17 alpha-acyloxy-21-chloro-21-deoxy derivatives.
    Sugai S; Akaboshi S; Ikegami S
    Chem Pharm Bull (Tokyo); 1983 Jan; 31(1):12-9. PubMed ID: 6850929
    [No Abstract]   [Full Text] [Related]  

  • 38. Prednicarbate activity and benefit/risk ratio in relation to other topical glucocorticoids.
    Schäfer-Korting M; Korting HC; Kerscher MJ; Lenhard S
    Clin Pharmacol Ther; 1993 Oct; 54(4):448-56. PubMed ID: 8222488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Systemic effect of diflucortolone valerate after dermal application (author's transl)].
    Wendt H; Reckers R
    Arzneimittelforschung; 1976; 26(7b):1509-13. PubMed ID: 188429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steroid-induced atrophy in an animal and human model.
    Kirby JD; Munro DD
    Br J Dermatol; 1976 Mar; 94 suppl 12():111-9. PubMed ID: 1268071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.